Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma
Conditions
- Refractory Multiple Myeloma
- Stage II Multiple Myeloma
- Stage III Multiple Myeloma
Interventions
- DRUG: melphalan
- DRUG: amifostine trihydrate
- PROCEDURE: peripheral blood stem cell transplantation
- GENETIC: fluorescence in situ hybridization
- PROCEDURE: bone marrow ablation with stem cell support
Sponsor
Fred Hutchinson Cancer Center
Collaborators